NPS Pharmaceuticals, Inc. (NPSP) Misses Q1 EPS by 1c

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q1 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $24.91 million.

For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Faraday Future stockholders approve $25M private placement proposal
• Hyperion DeFi (HYPD) Tops Q2 EPS by 57c